Please use this identifier to cite or link to this item:
|Title:||New insights into sinusoidal obstruction syndrome||Authors:||Piccin, Andrea
Sartori, Maria T
Van Schilfgaarde, Muriel
Pierro, Angela M D
|Keywords:||PAI-1:Ag;PAI-1:act;extracellular vesicle;sinusoidal obstruction syndrome;veno-occlusive disease||Keywords Plus:||PLATELET-DERIVED MICROPARTICLES;HEPATIC VENOOCCLUSIVE DISEASE;STEM-CELL TRANSPLANTATION;PLASMINOGEN-ACTIVATOR INHIBITOR-1;BONE-MARROW-TRANSPLANTATION;THROMBIN GENERATION;OCCLUSIVE DISEASE;TISSUE FACTOR;PROCOAGULANT;DIAGNOSIS||Mesh headings:||Endothelium, Vascular;Extracellular Vesicles;Hepatic Veno-Occlusive Disease;Plasminogen Activator Inhibitor 1||Secondary Mesh headings:||Adolescent;Biomarkers;Child;Child, Preschool;Female;Flow Cytometry;Hematopoietic Stem Cell Transplantation;Humans;Male;Transplantation, Autologous||Issue Date:||Oct-2017||Publisher:||WILEY||Journal:||Internal medicine journal||Abstract:||
Entry criteria included patients who developed sinusoidal obstruction syndrome (SOS) at a single centre from January 2000 to December 2011. Patients who underwent haemopoietic stem cell transplantation or actinomicyn-based chemotherapy for nephroblastoma were selected. The study group comprised five patients with SOS who were compared with a control group of seven patients without SOS.
|Appears in Collections:||Articles|
Show full item record
checked on May 3, 2021
checked on Sep 5, 2020
WEB OF SCIENCETM
checked on Dec 4, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.